ロード中...
Current regulatory approaches for accessing potential COVID-19 therapies
This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe...
保存先:
| 出版年: | J Pharm Policy Pract |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229878/ https://ncbi.nlm.nih.gov/pubmed/32454981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-020-00222-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|